Xarelto 20 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FUXVF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,592
Award facts
- Contract value 100% obligated
- $14,592.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,592.23 delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for the supply of Xarelto 20 mg tablets (90-count units). The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 27, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.999 billion global pharmaceutical support vehicle valued through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems through its extensive portfolio of medical product deliveries. The company's DLA contract vehicle enables the supply of a broad spectrum of pharmaceutical products, brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Xarelto order under this delivery order exemplifies AmerisourceBergen's role in providing essential medications to the federal medical supply chain, fulfilling the Defense Logistics Agency's pharmaceutical procurement requirements for military and defense-related healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FUXVF?
SPE2DB25FUXVF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 26, 2025.
How much is contract SPE2DB25FUXVF worth?
The government has obligated $14,592 on SPE2DB25FUXVF.
Is contract SPE2DB25FUXVF an order under another contract?
Yes. SPE2DB25FUXVF is a delivery order under SPE2DB25D3018, an indefinite delivery contract.
Was contract SPE2DB25FUXVF competed?
The extent of competition for SPE2DB25FUXVF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award